| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Clinical and economic impact of the nonresponder phenomenon – implications for systems based discovery
|
Jackson, David B.
|
|
2009
|
14 |
7-8 |
p. 380-385
6 p.
|
artikel
|
| 2 |
Contents
|
|
|
2009
|
14 |
7-8 |
p. i-
1 p.
|
artikel
|
| 3 |
Contents
|
|
|
2009
|
14 |
7-8 |
p. iii-
1 p.
|
artikel
|
| 4 |
Decision support methods for the detection of adverse events in post-marketing data
|
Hauben, M.
|
|
2009
|
14 |
7-8 |
p. 343-357
15 p.
|
artikel
|
| 5 |
Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: strategic considerations
|
Gabrielsson, Johan
|
|
2009
|
14 |
7-8 |
p. 358-372
15 p.
|
artikel
|
| 6 |
Healthy skepticism: assessing realistic model performance
|
Brown, Scott P.
|
|
2009
|
14 |
7-8 |
p. 420-427
8 p.
|
artikel
|
| 7 |
Human Microbiome Project—paving the way to a better understanding of ourselves and our microbes
|
Hsiao, William W.L.
|
|
2009
|
14 |
7-8 |
p. 331-333
3 p.
|
artikel
|
| 8 |
Insights into liaison between antiepileptic drugs and bone
|
Khanna, Suruchi
|
|
2009
|
14 |
7-8 |
p. 428-435
8 p.
|
artikel
|
| 9 |
In silico platform for xenobiotics ADME-T pharmacological properties modeling and prediction. Part I: beyond the reduction of animal model use
|
Huynh, Lucie
|
|
2009
|
14 |
7-8 |
p. 401-405
5 p.
|
artikel
|
| 10 |
In silico platform for xenobiotics ADME-T pharmacological properties modeling and prediction. Part II: the body in a Hilbertian space
|
Jacob, Alexandre
|
|
2009
|
14 |
7-8 |
p. 406-412
7 p.
|
artikel
|
| 11 |
Managing protein flexibility in docking and its applications
|
B-Rao, Chandrika
|
|
2009
|
14 |
7-8 |
p. 394-400
7 p.
|
artikel
|
| 12 |
Modulating receptor function through RAMPs: can they represent drug targets in themselves?
|
Sexton, Patrick M.
|
|
2009
|
14 |
7-8 |
p. 413-419
7 p.
|
artikel
|
| 13 |
Molecular perspectives on the non-responder phenomenon
|
Jackson, David B.
|
|
2009
|
14 |
7-8 |
p. 373-379
7 p.
|
artikel
|
| 14 |
Omic profiling for drug safety assessment: current trends and public–private partnerships
|
Gallagher, William M.
|
|
2009
|
14 |
7-8 |
p. 337-342
6 p.
|
artikel
|
| 15 |
Protein structure prediction and model quality assessment
|
Kryshtafovych, Andriy
|
|
2009
|
14 |
7-8 |
p. 386-393
8 p.
|
artikel
|
| 16 |
The genetics of a pharma merger
|
Sanseau, Philippe
|
|
2009
|
14 |
7-8 |
p. 334-336
3 p.
|
artikel
|
| 17 |
The use of combinatorial chemistry libraries for the discovery of biologically active substances
|
Edwards, Paul
|
|
2009
|
14 |
7-8 |
p. 436-437
2 p.
|
artikel
|
Tijdschrift beschrijving